293 related articles for article (PubMed ID: 16120783)
1. Dual modulation of endocannabinoid transport and fatty acid amide hydrolase protects against excitotoxicity.
Karanian DA; Brown QB; Makriyannis A; Kosten TA; Bahr BA
J Neurosci; 2005 Aug; 25(34):7813-20. PubMed ID: 16120783
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage.
Karanian DA; Karim SL; Wood JT; Williams JS; Lin S; Makriyannis A; Bahr BA
J Pharmacol Exp Ther; 2007 Sep; 322(3):1059-66. PubMed ID: 17545313
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological enhancement of endocannabinoid signaling reduces the cholinergic toxicity of diisopropylfluorophosphate.
Nallapaneni A; Liu J; Karanth S; Pope C
Neurotoxicology; 2008 Nov; 29(6):1037-43. PubMed ID: 18765251
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity.
Hampson RE; Miller F; Palchik G; Deadwyler SA
Neuropharmacology; 2011 May; 60(6):944-52. PubMed ID: 21288475
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
[TBL] [Abstract][Full Text] [Related]
6. Piperidine and piperazine inhibitors of fatty acid amide hydrolase targeting excitotoxic pathology.
Lamani M; Malamas MS; Farah SI; Shukla VG; Almeida MF; Weerts CM; Anderson J; Wood JT; Farizatto KLG; Bahr BA; Makriyannis A
Bioorg Med Chem; 2019 Dec; 27(23):115096. PubMed ID: 31629610
[TBL] [Abstract][Full Text] [Related]
7. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release.
Seillier A; Giuffrida A
Neuropharmacology; 2018 Mar; 130():1-9. PubMed ID: 29169961
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system.
Cravatt BF; Lichtman AH
Curr Opin Chem Biol; 2003 Aug; 7(4):469-75. PubMed ID: 12941421
[TBL] [Abstract][Full Text] [Related]
9. Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
Kokona D; Thermos K
Exp Eye Res; 2015 Jul; 136():45-58. PubMed ID: 25989217
[TBL] [Abstract][Full Text] [Related]
10. Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology.
Naidoo V; Karanian DA; Vadivel SK; Locklear JR; Wood JT; Nasr M; Quizon PM; Graves EE; Shukla V; Makriyannis A; Bahr BA
Neurotherapeutics; 2012 Oct; 9(4):801-13. PubMed ID: 22270809
[TBL] [Abstract][Full Text] [Related]
11. Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors.
Kelley BG; Thayer SA
Eur J Pharmacol; 2004 Aug; 496(1-3):33-9. PubMed ID: 15288572
[TBL] [Abstract][Full Text] [Related]
12. Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.
Fegley D; Kathuria S; Mercier R; Li C; Goutopoulos A; Makriyannis A; Piomelli D
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8756-61. PubMed ID: 15138300
[TBL] [Abstract][Full Text] [Related]
13. Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease.
Lastres-Becker I; de Miguel R; De Petrocellis L; Makriyannis A; Di Marzo V; Fernández-Ruiz J
J Neurochem; 2003 Mar; 84(5):1097-109. PubMed ID: 12603833
[TBL] [Abstract][Full Text] [Related]
14. The endocannabinoid transport inhibitor AM404 modulates nociception in cholestasis.
Hasanein P
Neurosci Lett; 2009 Oct; 462(3):230-4. PubMed ID: 19616063
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of kainic acid-induced status epilepticus by inhibition of endocannabinoid transport and degradation in guinea pigs.
Shubina L; Aliev R; Kitchigina V
Epilepsy Res; 2015 Mar; 111():33-44. PubMed ID: 25769371
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.
Glaser ST; Deutsch DG; Studholme KM; Zimov S; Yazulla S
Vis Neurosci; 2005; 22(6):693-705. PubMed ID: 16469181
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor of Endocannabinoid Deactivation Protects Against In Vitro and In Vivo Neurotoxic Effects of Paraoxon.
Farizatto KLG; McEwan SA; Naidoo V; Nikas SP; Shukla VG; Almeida MF; Byrd A; Romine H; Karanian DA; Makriyannis A; Bahr BA
J Mol Neurosci; 2017 Sep; 63(1):115-122. PubMed ID: 28803438
[TBL] [Abstract][Full Text] [Related]
18. A new generation fatty acid amide hydrolase inhibitor protects against kainate-induced excitotoxicity.
Naidoo V; Nikas SP; Karanian DA; Hwang J; Zhao J; Wood JT; Alapafuja SO; Vadivel SK; Butler D; Makriyannis A; Bahr BA
J Mol Neurosci; 2011 Mar; 43(3):493-502. PubMed ID: 21069475
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice.
Naderi N; Aziz Ahari F; Shafaghi B; Najarkolaei AH; Motamedi F
J Neural Transm (Vienna); 2008 Nov; 115(11):1501-11. PubMed ID: 18575801
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
